Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide.

[1]  L. Ferrucci,et al.  Gender specificity of altered human immune cytokine profiles in aging , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  J. Curnow,et al.  Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4(+) T cells during ageing , 2010 .

[3]  D. Taub,et al.  Human CD4 8 T cells are a distinctive immunoregulatory subset , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Diana M. Mitchell,et al.  Distinct Roles for IL-2 and IL-15 in the Differentiation and Survival of CD8+ Effector and Memory T Cells , 2010, The Journal of Immunology.

[5]  M. Salmon,et al.  Decreased TNF-α synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging , 2009, The Journal of experimental medicine.

[6]  G. Pawelec,et al.  Mechanisms of immunosenescence , 2009, Immunity & Ageing.

[7]  Lisa Morrison,et al.  Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases. , 2009, Blood.

[8]  J. Wright,et al.  Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer , 2009, Journal of clinical pharmacology.

[9]  E. Montecino-Rodriguez,et al.  The ageing immune system: is it ever too old to become young again? , 2009, Nature Reviews Immunology.

[10]  A. Dalgleish,et al.  The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells , 2009, Cancer Immunology, Immunotherapy.

[11]  Christian R. Gomez,et al.  Innate immunity and aging , 2008, Experimental Gerontology.

[12]  Y. Belkaid,et al.  Functional Regulatory T Cells Accumulate in Aged Hosts and Promote Chronic Infectious Disease Reactivation1 , 2008, The Journal of Immunology.

[13]  R. Kilpatrick,et al.  Response to Comment on “Homeostasis of the Naive CD4+ T Cell Compartment during Aging” , 2008, The Journal of Immunology.

[14]  P. Krammer,et al.  Concepts of activated T cell death. , 2008, Critical reviews in oncology/hematology.

[15]  M. Czuczman,et al.  Immunomodulatory drugs stimulate natural killer‐cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti‐tumour activity of rituximab in vivo , 2007, British journal of haematology.

[16]  Sudhanshu Agrawal,et al.  Altered Innate Immune Functioning of Dendritic Cells in Elderly Humans: A Role of Phosphoinositide 3-Kinase-Signaling Pathway1 , 2007, The Journal of Immunology.

[17]  B. Huber,et al.  Age-Associated Decline in Effective Immune Synapse Formation of CD4+ T Cells Is Reversed by Vitamin E Supplementation1 , 2007, The Journal of Immunology.

[18]  A. Rudensky,et al.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice , 2007, Nature Immunology.

[19]  J. Tay,et al.  Biology of Dendritic Cells in Aging , 2007, Journal of Clinical Immunology.

[20]  Sudhir Gupta,et al.  TNF-α-induced apoptosis in human naïve and memory CD8+ T cells in aged humans , 2006, Experimental Gerontology.

[21]  Sudhir Gupta,et al.  TNF-alpha-induced apoptosis in human naïve and memory CD8+ T cells in aged humans. , 2006, Experimental gerontology.

[22]  Sudhir Gupta,et al.  A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis , 2006, Immunity & Ageing.

[23]  C. Hughes,et al.  Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[24]  S. Swain,et al.  Homeostasis and the age-associated defect of CD4 T cells. , 2005, Seminars in immunology.

[25]  P. Moss,et al.  The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age , 2005, Clinical and experimental immunology.

[26]  A. Vallejo,et al.  The Influence of Age on T Cell Generation and TCR Diversity1 , 2005, The Journal of Immunology.

[27]  R. Effros,et al.  The role of CD8+ T‐cell replicative senescence in human aging , 2005, Discovery medicine.

[28]  S. Watson,et al.  Immunological Effects of Transgenic Constitutive Expression of the Type 1 Sphingosine 1-Phosphate Receptor by Mouse Lymphocytes1 , 2005, The Journal of Immunology.

[29]  P. Richardson,et al.  Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application , 2005, British journal of haematology.

[30]  H. Fine,et al.  Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[31]  T. Waldmann,et al.  Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Cambier,et al.  Ageing, autoimmunity and arthritis: Senescence of the B cell compartment – implications for humoral immunity , 2004, Arthritis research & therapy.

[33]  Sudhir Gupta,et al.  Characterization of naı̈ve, memory and effector CD8+ T cells: effect of age , 2004, Experimental Gerontology.

[34]  B. Nelson.  IL-2, Regulatory T Cells, and Tolerance , 2004, The Journal of Immunology.

[35]  N. Munshi,et al.  Immunomodulatory drug costimulates T cells via the B7-CD28 pathway. , 2004, Blood.

[36]  N. Greig,et al.  Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity. , 2003, Journal of medicinal chemistry.

[37]  Michael R. Green,et al.  Transcriptional Program of Apoptosis Induction following Interleukin 2 Deprivation: Identification of RC3, a Calcium/Calmodulin Binding Protein, as a Novel Proapoptotic Factor , 2003, Molecular and Cellular Biology.

[38]  G. Wolbring,et al.  Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs , 2003, Journal of Pharmacology and Experimental Therapeutics.

[39]  Kara M. Johnson,et al.  Aging and developmental transitions in the B cell lineage. , 2002, International immunology.

[40]  C. Franceschi,et al.  Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. , 2000, Blood.

[41]  S. Swain,et al.  Interleukin 2, but Not Other Common γ Chain–Binding Cytokines, Can Reverse the Defect in Generation of Cd4 Effector T Cells from Naive T Cells of Aged Mice , 1999, The Journal of experimental medicine.

[42]  P. Haslett,et al.  Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. , 1999, Journal of immunology.

[43]  T. Waldmann,et al.  Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Cossarizza,et al.  Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. , 1998, International immunology.

[45]  P. Haslett,et al.  Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset , 1998, The Journal of experimental medicine.

[46]  Gilla Kaplan,et al.  Selection of Novel Analogs of Thalidomide with Enhanced Tumor Necrosis Factor α Inhibitory Activity , 1996, Molecular medicine.

[47]  I. Rea,et al.  Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. , 1996, Gerontology.

[48]  H. Ostrer,et al.  Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. , 1996, Journal of immunology.

[49]  C. Caruso,et al.  Cytokine production pathway in the elderly , 1996, Immunologic research.

[50]  A. Eastman,et al.  Apoptosis in an Interleukin-2-dependent Cytotoxic T Lymphocyte Cell Line Is Associated with Intracellular Acidification , 1995, The Journal of Biological Chemistry.

[51]  M. Weksler,et al.  Immunological studies of aging. Normal B-cell repertoire in aged mice: studies at a clonal level. , 1989, Cellular immunology.

[52]  M. Weksler,et al.  Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. , 1981, The Journal of clinical investigation.